Business Description
Alzinova AB
ISIN : SE0007413455
Compare
Compare
Traded in other countries / regions
ALZ.Sweden78D.Germany IPO Date
2020-12-15Description
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.53 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -3.6 | |||||
| 3-Year EPS without NRI Growth Rate | -3.8 | |||||
| 3-Year FCF Growth Rate | 10.2 | |||||
| 3-Year Book Growth Rate | -22.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.61 | |||||
| 9-Day RSI | 46.28 | |||||
| 14-Day RSI | 40.05 | |||||
| 6-1 Month Momentum % | -30.57 | |||||
| 12-1 Month Momentum % | -40.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.97 | |||||
| Cash Ratio | 2.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.2 | |||||
| Shareholder Yield % | -51.77 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7360.74 | |||||
| Operating Margin % | -6119.26 | |||||
| Net Margin % | -6103.7 | |||||
| FCF Margin % | -12720.83 | |||||
| ROE % | -14.68 | |||||
| ROA % | -13.85 | |||||
| ROIC % | -18.03 | |||||
| ROCE % | -14.49 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 199.93 | |||||
| PB Ratio | 0.47 | |||||
| Price-to-Tangible-Book | 3.25 | |||||
| EV-to-EBIT | -2.43 | |||||
| EV-to-Forward-EBIT | -1.09 | |||||
| EV-to-EBITDA | -2.43 | |||||
| EV-to-Forward-EBITDA | -1.09 | |||||
| EV-to-Revenue | 147.6 | |||||
| EV-to-Forward-Revenue | 3.32 | |||||
| EV-to-FCF | -0.85 | |||||
| Price-to-Net-Current-Asset-Value | 3.25 | |||||
| Price-to-Net-Cash | 4.87 | |||||
| Earnings Yield (Greenblatt) % | -41.19 | |||||
| FCF Yield % | -56.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alzinova AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.024 | ||
| EPS (TTM) (€) | -0.038 | ||
| Beta | 2.26 | ||
| Volatility % | 62.94 | ||
| 14-Day RSI | 40.05 | ||
| 14-Day ATR (€) | 0.005761 | ||
| 20-Day SMA (€) | 0.094915 | ||
| 12-1 Month Momentum % | -40.32 | ||
| 52-Week Range (€) | 0.0862 - 0.297 | ||
| Shares Outstanding (Mil) | 44.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alzinova AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alzinova AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alzinova AB Frequently Asked Questions
What is Alzinova AB(STU:78D)'s stock price today?
The current price of STU:78D is €0.10. The 52 week high of STU:78D is €0.30 and 52 week low is €0.09.
When is next earnings date of Alzinova AB(STU:78D)?
The next earnings date of Alzinova AB(STU:78D) is 2024-05-28.
Does Alzinova AB(STU:78D) pay dividends? If so, how much?
Alzinova AB(STU:78D) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers